Get the Stockscreener App
137.44
1.61%
-2.255
Grail Inc stock is traded at $137.44, with a volume of 346.61K.
It is down -1.61% in the last 24 hours and up +81.11% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$139.70
Open:
$136
24h Volume:
346.61K
Relative Volume:
0.32
Market Cap:
$6.14B
Revenue:
$156.12M
Net Income/Loss:
$-395.33M
P/E Ratio:
-13.25
EPS:
-10.3758
Net Cash Flow:
$-292.33M
1W Performance:
+3.65%
1M Performance:
+81.11%
6M Performance:
+176.05%
1Y Performance:
+82.00%
1-Day Range:
$132.09
$139.50
1-Week Range:
$133.31
$144.18
52-Week Range:
$41.50
$166.47
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
137.44 | 6.14B | 156.12M | -395.33M | -292.33M | -10.38 |
TMO
Thermo Fisher Scientific Inc
|
693.35 | 256.36B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
231.68 | 162.87B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
402.42 | 58.01B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
176.41 | 49.74B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
269.96 | 44.44B | 16.63B | 1.39B | 2.12B | 8.0674 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-26 | Initiated | RBC Capital Mkts | Sector Perform |
| Sep-09-26 | Resumed | UBS | Buy |
| Jun-05-26 | Initiated | Goldman | Neutral |
| Jun-02-26 | Resumed | Wolfe Research | Peer Perform |
| Apr-10-26 | Initiated | Mizuho | Neutral |
| Mar-18-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | TD Cowen | Hold |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| Nov-12-25 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
View All
Grail Inc Stock (GRAL) Latest News
Grail Stock Hit a 12-Month High After Its FDA Panel Win. But Here's the Risk Investors Shouldn't Ignore. - The Motley Fool
GRAIL's Chief Growth Officer Andrew Partridge Sells 7,873 Shares to Cover Tax Withholding - Kalkine Media
Grail CFO Aaron Freidin sells $3.46m in company stock - Investing.com
To cover vesting taxes, GRAIL (GRAL) CFO Aaron Freidin sells 23,619 shares. - Stock Titan
GRAIL Inc. Officer Andrew Partridge Files Form 144 to Sell 7,873 Shares for RSU Tax Withholding - Kalkine Media
An officer sold 7,873 shares to cover vesting taxes at GRAIL (NASDAQ: GRAL). - Stock Titan
After 45,840 shares vest, a GRAIL (GRAL) officer proposes selling stock to cover taxes. - Stock Titan
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October - The Motley Fool
Grail CFO Aaron Freidin sells $382,679 in company stock By Investing.com - Investing.com South Africa
Grail CFO Aaron Freidin sells $382,679 in company stock - Investing.com
Grail CEO Joshua Ofman sells $6.0m in company stock on Sept. 21 - Investing.com
Form 4 Grail Inc For: 26 September By Investing.com - Investing.com Nigeria
GRAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 4 Deadline in Securities Class ActionGRAL - TMX Newsfile
At prices up to $95 a share, GRAIL (GRAL) CFO Aaron Freidin sold 4,100 shares under a trading plan. - Stock Titan
Up to $5.8M in insider stock may be sold at GRAIL, Inc. (GRAL) - Stock Titan
GRAIL, Inc.Common Stock (Nasdaq:GRAL) Price Chart - The Chronicle-Journal
Analysts Offer Insights on NA Companies: Chime Financial, Inc. Class A (CHYM), GRAIL Inc (GRAL) and ServiceTitan, Inc. Class A (TTAN) - The Globe and Mail
UBS Initiates Coverage of Grail With Buy Rating, Caris, Tempus, Twist With Neutral - GenomeWeb
Grail CFO Sells 7,900 Shares Amid Strong Stock Performance - intellectia.ai
Grail CFO Aaron Freidin Sells 7,900 Shares for $672,000 - Yahoo Finance
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test - Yahoo Finance
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Have Insiders Sold GRAIL Shares Recently? - simplywall.st
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Moomoo
GRAIL (GRAL) Institutional Ownership 2026 $GRAL - MarketBeat
Grail CFO Aaron Freidin sells $671,579 in company stock By Investing.com - Investing.com South Africa
Grail CFO Aaron Freidin sells $671,579 in company stock - Investing.com
Grail CEO Joshua Ofman sells $425,098 in company stock - Investing.com
GRAIL CFO sells 7,900 shares at $85.01 avg | GRAL Insider Trading - Stock Titan
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference - TradingView
CEO of GRAIL (GRAL) sells 5,000 shares in preset trade - Stock Titan
GRAIL (NASDAQ: GRAL) insider Joshua Ofman plans to sell 10,000 shares - Stock Titan
GRAIL, Inc. (NASDAQ: GRAL) officer to sell 12,000 shares - Stock Titan
Biotech Frenzy Sends GRAIL Soaring Ahead of FDA Showdown - TipRanks
Investigation announced for Long-Term Investors in shares of GRAIL, Inc. (NASDAQ: GRAL) over potential Wrongdoing - openPR.com
GRAIL (GRAL) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Post-Report: The Market Price Advances 6.19% in Latest TradingGross Profit Margin - dars.gov.et
GRAIL (GRAL) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Post-Report: The Market Price Advances 6.19% in Latest TradingQuarterly Profit Report - Vinanet
Grail Stock Rockets Back As Traders Buy The Dip - TipRanks
GRAIL (GRAL), What Is Behind The Fresh Attention On The Stock? - simplywall.st
Why Silver Grail Resources Ltd stock is skyrocketing today - Wealth Awesome
Whoop expands Advanced Labs to non-members, adds Grail’s multi-cancer detection test to lineup - Fierce Healthcare
Russell Investments Group Ltd. Has $1.94 Million Holdings in GRAIL, Inc. $GRAL - MarketBeat
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
How (GRAL) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
GRAL Q2 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineEarnings Season Review - Vinanet
GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting - MarketBeat
GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting - Yahoo Finance
GRAL|Grail Inc|Price:68.180|Chg%:-0.760 - TradingKey
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Grail Inc Stock (GRAL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Andrew Partridge | Officer |
Oct 05 '26 |
Proposed Sale |
146.39 |
7,873 |
1,152,533 |
0 |
| Freidin Aaron | Chief Financial Officer |
Oct 05 '26 |
Sale |
146.39 |
23,619 |
3,457,585 |
225,364 |
| Aaron Freidin | Officer |
Oct 05 '26 |
Proposed Sale |
146.39 |
23,619 |
3,457,600 |
0 |
| Ofman Joshua J. | Chief Executive Officer |
Sep 21 '26 |
Option Exercise |
14.00 |
26,452 |
370,328 |
423,723 |
| Freidin Aaron | Chief Financial Officer |
Sep 21 '26 |
Sale |
93.34 |
4,100 |
382,679 |
248,983 |
| Ofman Joshua J. | Chief Executive Officer |
Sep 21 '26 |
Sale |
97.74 |
61,452 |
6,006,378 |
362,271 |
| JOSHUA OFMAN | Director |
Sep 21 '26 |
Proposed Sale |
80.77 |
71,452 |
5,771,178 |
0 |
| Freidin Aaron | Chief Financial Officer |
Aug 27 '26 |
Sale |
85.01 |
7,900 |
671,579 |
253,083 |
| JOSHUA OFMAN | Director |
Aug 27 '26 |
Proposed Sale |
79.59 |
10,000 |
795,900 |
0 |
| AARON FREIDIN | Officer |
Aug 27 '26 |
Proposed Sale |
79.59 |
12,000 |
955,080 |
0 |
1.08%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):